Additionally, in HD cell models treated with the SIRT3 activator viniferin, the acetylation of SOD2 was reduced and mitochondrial function and antioxidant capacity was enhanced by activating the AMPK pathway (Fu et al., 2012). This evidence concerns the gene SIRT3 and Huntington disease.